Artemisia princeps Pamp. Essential Oil and Its Constituents Eucalyptol and α-terpineol Ameliorate Bacterial Vaginosis and Vulvovaginal Candidiasis in Mice by Inhibiting Bacterial Growth and NF-κB Activation

Abstract

To investigate the inhibitory effects of Artemisia princeps Pamp. (family Asteraceae) essential oil (APEO) and its main constituents against bacterial vaginosis and vulvovaginal candidiasis, their antimicrobial activities against Gardnerella vaginalis and Candida albicans in vitro and their anti-inflammatory effects against G. vaginalis-induced vaginosis and vulvovaginal candidiasis were examined in mice. APEO and its constituents eucalyptol and α-terpineol were found to inhibit microbe growths. α-Terpineol most potently inhibited the growths of G. vaginalis and C. albicans with MIC values of 0.06 and 0.125 % (v/v), respectively. The antimicrobial activity of α-terpineol was found to be comparable to that of clotrimazole. Intravaginal treatment with APEO, eucalyptol, or α-terpineol significantly decreased viable G. vaginalis and C. albicans numbers in the vaginal cavity and myeloperoxidase activity in mouse vaginal tissues compared with controls. These agents also inhibited the expressions of proinflammatory cytokines (IL-1β, IL-6, TNF-α), COX-2, iNOS, and the activation of NF-κB and increased expression of the anti-inflammatory cytokine IL-10. In addition, they inhibited the expressions of proinflammatory cytokines and the activation of NF-κB in lipopolysaccharide-stimulated peritoneal macrophages, and α-terpineol most potently inhibited the expressions of proinflammatory cytokines and NF-κB activation. Based on these findings, APEO and its constituents, particularly α-terpineol, ameliorate bacterial vaginosis and vulvovaginal candidiasis by inhibiting the growths of vaginal pathogens and the activation of NF-κB.

Key words

Asteraceae - Artemisia princeps - essential oil - α-terpineol - vaginosis - candidiasis - antimicrobial

References

• 1 Pybus V, Onderdonk A B. Microbial interactions in the vaginal ecosystem, with emphasis on the pathogenesis of bacterial vaginosis.  Microbes Infect. 1999;  1 285-292
• 2 Sobel J D. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis.  Am J Obstet Gynecol. 1985;  152 924-935
• 3 Amsel R, Totten P A, Spiegel C A, Chen K C, Eschenbach D, Holmes K K. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.  Am J Med. 1983;  74 14-22
• 4 Hawes S E, Hillier S L, Benedetti J, Stevens C E, Koutsky L A, Wolner-Hanssen P, Holmes K K. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections.  J Infect Dis. 1996;  174 1058-1063
• 5 Catlin B W. Gardnerella vaginalis: characteristics, clinical considerations, and controversies.  Clin Microbiol Rev. 1992;  5 213-237
• 6 Sobel J D. Bacterial vaginosis.  Annu Rev Med. 2000;  51 349-356
• 7 Hill G B. The microbiology of bacterial vaginosis.  Am J Obstet Gynecol. 1993;  169 450-454
• 8 Centers for Disease Control and Prevention . Sexually transmitted disease treatment guidelines, 2006.  MMWR Recomm Rep. 2006;  55?(RR11) 1-94
• 9 Sobel J D. Vulvovaginal candidosis.  Lancet. 2007;  369 1961-1971
• 10 Pappas P G, Kauffman C A, Andes D, Benjamin jr. D K, Calandra T F, Edwards jr. J E, Filler S G, Fisher J F, Kullberg B J, Ostrosky-Zeichner L, Reboli A C, Rex J H, Walsh T J, Sobel J D. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.  Clin Infect Dis. 2009;  48 503-535
• 11 Hammer K A, Carson C F, Riley T V. Antifungal effects of Melaleuca alternifolia (tea tree) oil and its components on Candida albicans, Candida glabrata and Saccharomyces cerevisiae.  J Antimicrob Chemother. 2004;  53 1081-1085
• 12 Maruyama N, Takizawa T, Ishibashi H, Hisajima T, Inouye S, Yamaguchi H, Abe S. Protective activity of geranium oil and its component, geraniol, in combination with vaginal washing against vaginal candidiasis in mice.  Biol Pharm Bull. 2008;  31 1501-1506
• 13 Cha J D, Jeong M R, Jeong S I, Moon S E, Kil B S, Yun S I, Lee K Y, Song Y H. Chemical composition and antimicrobial activity of the essential oil of Cryptomeria japonica.  Phytother Res. 2007;  21 295-299
• 14 Kotan R, Cakir A, Dadasoglu F, Aydin T, Cakmakci R, Ozer H, Kordali S, Mete E, Dikbas N. Antibacterial activities of essential oils and extracts of Turkish Achillea, Satureja and Thymus species against plant pathogenic bacteria.  J Sci Food Agric. 2010;  90 145-160
• 15 Oh T Y, Ahn G J, Choi S M, Ahn B O, Kim W B. Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, an Artemisia asiatica extract.  World J Gastroenterol. 2005;  11 7450-7456
• 16 Ryu K R, Choi J Y, Chung S, Kim D H. Anti-scratching behavioral effect of the essential oil and phytol isolated from Artemisia princeps Pamp. in mice.  Planta Med. 2011;  77 22-26
• 17 Kang T H, Pae H O, Jeong S J, Yoo J C, Choi B M, Jun C D, Chung H T, Miyamoto T, Higuchi R, Kim Y C. Scopoletin: an inducible nitric oxide synthesis inhibitory active constituent from Artemisia feddei.  Planta Med. 1999;  65 400-403
• 18 Min S W, Kim N J, Baek N I, Kim D H. Inhibitory effect of eupatilin and jaceosidin isolated from Artemisia princeps on carrageenan-induced inflammation in mice.  J Ethnopharmacol. 2009;  125 497-500
• 19 Song H J, Shin C Y, Oh T Y, Sohn U D. The protective effect of eupatilin on indomethacin-induced cell damage in cultured feline ileal smooth muscle cells: involvement of HO-1 and ERK.  J Ethnopharmacol. 2008;  118 94-101
• 20 Kordali S, Cakir A, Mavi A, Kilic H, Yildirim A. Screening of chemical composition and antifungal and antioxidant activities of the essential oils from three Turkish Artemisia species.  J Agric Food Chem. 2005;  53 1408-1416
• 21 Cha J D, Jeong M R, Choi H J, Jeong S I, Moon S E, Yun S I, Kim Y H, Kil B S, Song Y H. Chemical composition and antimicrobial activity of the essential oil of Artemisia lavandulaefolia.  Planta Med. 2005;  71 575-577
• 22 Cha J D, Jung E K, Kil B S, Lee K Y. Chemical composition and antibacterial activity of essential oil from Artemisia feddei.  J Microbiol Biotechnol. 2007;  17 2061-2065
• 23 Strandberg K L, Peterson M L, Lin Y C, Pack M C, Chase D J, Schlievert P M. Glycerol monolaurate inhibits Candida and Gardnerella vaginalis in vitro and in vivo but not Lactobacillus.  Antimicrob Agents Chemother. 2010;  54 597-601
• 24 Joh E H, Kim D H. Lancemaside A inhibits lipopolysaccharide-induced inflammation by targeting LPS/TLR4 complex.  J Cell Biochem. 2010;  111 865-871
• 25 Sobel J D. Bacterial vaginosis.  Annu Rev Med. 2000;  51 349-356
• 26 Rollinger J M, Hornick A, Langer T, Stuppner H, Prast H. Acetylcholinesterase inhibitory activity of scopolin and scopoletin discovered by virtual screening of natural products.  J Med Chem. 2004;  47 6248-6254
• 27 Cha J D, Moon S E, Kim H Y, Lee J C, Lee K Y. The essential oil isolated from Artemisia capillaris prevents LPS-induced production of NO and PGE(2) by inhibiting MAPK-mediated pathways in RAW 264.7 macrophages.  Immunol Invest. 2009;  38 483-497